Clinical Trials Browser

INDUSTRY × Neoplasms × elotuzumab × Clear all

NCT00425347 2009-09-23

Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Neoplasms